2-(5-amino-3-methyl-1H-pyrazol-1-yl)-5,6,7,8-tetrahydroquinazolin-4(3H)-one, 95.0%, 250mg

2,4-Difluoro-3-(trifluoromethyl)benzoic acid, 97%, 250mg

m-PEG-OH MW 550, Mw550, 1kg

Sodium stannate trihydrate, min. 94%, pure, 1 kg, plastic packaging.

4,4'-Dihydroxybiphenyl>99.0%(GC)500g

(2s,4s)-1-(((9h-Fluoren-9-yl)methoxy)carbonyl)-4-(trifluoromethyl)pyrrolidine-2-carboxylic acid, 98%, 250mg

(1Z)-N'-hydroxy-2-(1-propyl-4-piperidinyl)ethanimidamide, 95.0%, 5g

2,7-Bis[N-(1-naphthyl)anilino]-9,9'-spirobi[9H-fluorene]>98.0%(HPLC)(N)200mg

2-chloro-6-methoxy-1,4-dihydroquinazolin-4-one, 97%, 100mg

D-(-)-2-(2,5-Dihydrophenyl)glycine>97.0%(T)5g

6-(2-thienyl)-2-thioxo-2,3-dihydropyrimidin-4(1{H})-one, 95.0%, 1g

(1S)-1-(2-FLUORO-4-METHOXYPHENYL)ETHYLAMINE, 95%, 250mg

Gaboxadol Hydrochloride>98.0%(HPLC)25mg